TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,095,534 | +9.9% | 2,235,783 | 0.0% | 0.06% | -13.0% |
| Q4 2022 | $996,488 | -34.6% | 2,235,783 | 0.0% | 0.07% | -36.1% |
| Q3 2022 | $1,524,000 | -16.1% | 2,235,783 | 0.0% | 0.11% | -23.4% |
| Q2 2022 | $1,816,000 | -42.4% | 2,235,783 | 0.0% | 0.14% | -29.5% |
| Q1 2022 | $3,152,000 | -49.9% | 2,235,783 | +42.5% | 0.20% | -44.4% |
| Q4 2021 | $6,293,000 | – | 1,569,300 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $3,152,000 | 0.20% |
| Baker Brothers Advisors | 7,624,835 | $10,751,000 | 0.06% |
| ArrowMark Colorado Holdings LLC | 3,735,237 | $5,267,000 | 0.05% |
| Golden State Equity Partners | 22,133 | $31,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 256,395 | $362,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,000 | $76,000 | 0.00% |
| Qube Research & Technologies Ltd | 47,467 | $67,000 | 0.00% |
| Nuveen Asset Management, LLC | 53,809 | $82,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,064 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 15,767 | $22,000 | 0.00% |